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Abstract
Protozoa and bacteria infect various types of phagocytic cells including macrophages, monocytes, dendritic cells and
eosinophils. However, it is not clear which of these cells process and present microbial antigens in vivo and in which cellular
compartments parasite peptides are loaded onto Major Histocompatibility Complex molecules. To address these issues, we
have infected susceptible BALB/c (H-2
d) mice with a recombinant Leishmania major parasite expressing a fluorescent tracer.
To directly visualize the antigen presenting cells that present parasite-derived peptides to CD4
+ T cells, we have generated a
monoclonal antibody that reacts to an antigenic peptide derived from the parasite LACK antigen bound to I-A
d Major
Histocompatibility Complex class II molecule. Immunogold electron microscopic analysis of in vivo infected cells showed
that intracellular I-A
d/LACK complexes were present in the membrane of amastigote-containing phagosomes in dendritic
cells, eosinophils and macrophages/monocytes. In both dendritic cells and macrophages, these complexes were also
present in smaller vesicles that did not contain amastigote. The presence of I-A
d/LACK complexes at the surface of dendritic
cells, but neither on the plasma membrane of macrophages nor eosinophils was independently confirmed by flow
cytometry and by incubating sorted phagocytes with highly sensitive LACK-specific hybridomas. Altogether, our results
suggest that peptides derived from Leishmania proteins are loaded onto Major Histocompatibility Complex class II
molecules in the phagosomes of infected phagocytes. Although these complexes are transported to the cell surface in
dendritic cells, therefore allowing the stimulation of parasite-specific CD4
+ T cells, this does not occur in other phagocytic
cells. To our knowledge, this is the first study in which Major Histocompatibility Complex class II molecules bound to
peptides derived from a parasite protein have been visualized within and at the surface of cells that were infected in vivo.
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Introduction
The initiation of an adaptive immune response against a
pathogen relies on the loading of microbial peptides onto Major
Histocompatibility Complex (MHC) molecules in Antigen Pre-
senting Cells (APCs) and on the recognition of these peptide/
MHC complexes by T lymphocytes. Therefore, identifying the cell
types that present peptide/MHC to T cells and the mechanisms
that lead to the formation of these complexes is critical for
understanding host-pathogen interactions. In contrast to soluble
antigens that enter APCs through passive or receptor-mediated
endocytosis, particles that are larger than 0.5 mm in size such as
bacteria and protozoa enter host cells through phagocytosis [1].
This process has been evidenced, at least in vitro, in several cell
types including macrophages, monocytes, dendritic cells (DCs),
neutrophils and eosinophils, leading to the formation of pathogen-
containing phagosomes in the cell [2]. In most cases, phagosomes
fuse with endosomes and eventually with lysosomes leading to
phagolysosomes. The final outcome of this process depends on the
nature of the infected cell. In macrophages and neutrophils,
phagolysosomes exhibit a low pH and contain high levels of
proteases resulting in efficient pathogen degradation. DC
phagolysosomes exhibit a higher pH and pathogen degradation
is therefore reduced in these cells [3]. While the phagocytic activity
of eosinophils has been recognized for a long time, almost nothing
is known on their phagosomes. Of note, a number of pathogens
have developed survival strategies to avoid degradation by
phagocytic cells [4].
As phagosomes are part of the endocytic pathway, many studies
have investigated the role of these organelles in the processing and
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marrow-derived macrophages or DCs, as well as macrophage cell
lines were incubated in vitro with either antigen-coupled latex
beads or live or killed pathogens and further analyzed by confocal
or electron microscopy. In some studies, latex beads phagosomes
were purified due to their flotation capabilities and analyzed for
their protein content by 2-D gels or Western Blotting. Results
indicated that latex beads phagosomes expressed various mole-
cules involved in antigen presentation such as MHC class I and II,
H2-DM, the invariant chain (Ii), cathepsins and Transporters
associated with Antigen Processing (TAP) [5–10]. Studies with
bacteria- or protozoa- containing phagosomes have revealed a
more complex situation. While MHC class II molecules have been
evidenced on the phagosomes of murine peritoneal macrophages
incubated with heat-killed Listeria monocytogenes [11], they were not
found on Legionella pneumophila-containing phagosomes in human
monocytes [12]. In the case of Mycobacterium tuberculosis, both MHC
class I and class II molecules were detected on the phagosome
membrane in human monocytes infected with both live and heat
killed bacteria [13]. In agreement with these results, phagosomes
purified from a human monocytic leukemia cell line that had been
incubated with heat-killed Mycobacterium tuberculosis stimulated
pathogen-specific T cell hybridomas to secrete IL-2 [14]. Other
studies were performed using bone marrow-derived macrophages
or DCs that were infected in vitro with the intracellular parasite
Leishmania major. Data showed that L. major amastigotes settled in
acidic parasitophorous vacuoles exhibiting all the features of
phagolysosomes including the presence of lysosome markers such
as LAMP-1, LAMP-2 and rab7p [15]. In addition, the phagosome
membrane contained both MHC II and H-2M molecules
suggesting that MHC/peptide complexes were assembled in the
phagosome [15]. However, at least in macrophages, MHC class II
molecules appeared to be retained in the phagolysosome and part
of these molecules were internalized by amastigotes possibly
preventing L. major-infected cells to present parasite as well as
exogenous antigens [16,17].
Here, we have sought to visualize peptide/MHC complexes at
the surface and in intracellular compartments of various
phagocytic cells infected with L. major in vivo. To this aim, we
have generated a monoclonal antibody (mAb) that reacts with high
avidity to a peptide derived from the Leishmania LACK antigen
bound to I-A
d. This antigen was chosen because it was
immunodominant and expressed in amastigotes, and because it
induced a strong protective immune response when used as a
vaccine in susceptible BALB/c mice [18,19]. Furthermore, a
LACK immunodominant peptide has been identified, i.e.
LACK156-173, and extensively characterized [20]. This mAb was
successfully used to analyze the distribution of I-A
d/LACK
complexes at the surface and in the different intracellular
compartments of various cell types that had been infected in vivo
with Leishmania major.
Results
I-A
d/LACK complexes can be visualized on the cell
surface and within intracellular compartments using the
mAb 2C44
To generate a mAb reacting to LACK156–173 bound to I-A
d,w e
injected I-A
d/LACK dimers into 16.2b T Cell Receptor (TCR)
transgenic mice that exhibit an increased frequency of LACK-
specific T cells as the result of the expression of the b chain of a
LACK-specific TCR [21]. We expected CD4
+ T cells from these
animals to provide increased help to B cells possibly resulting in
the generation of a higher number of plasmocytes and increasing
the probability to obtain B cell hybridomas secreting mAbs
reacting to I-A
d/LACK. Lymph node (LN) cells from immunized
mice were used to generate B cell hybridomas, and hybridoma
supernatants were tested for the ability to stain I-A
d-expressing
fibroblasts pulsed with LACK156–173 but not OVA323–339. Four
mAbs were obtained and further characterized for their specificity
and avidity for their common I-A
d/LACK ligand. Among these
mAbs, 2C44 was the only one that stained LN cells from LACK-
immunized BALB/c mice but not those from OVA-immunized
mice (Supplementary Figure 1). Furthermore, 2C44 exhibited a
very high avidity for I-A
d/LACK (1.1 nM) with association (k1)
and dissociation (k21) rate constants of 6.64610
4 M
21 s
21 and
7.6610
25 s
21 (Supplementary Table 1).
To further characterize the specificity of 2C44, BALB/c (H-2
d),
C3H (H-2
k), C57BL/6 (H-2
b) and NOD (H-2
g7) mice were
immunized with LACK or OVA. LN CD11c
+ cells were purified 2
days later and analyzed by flow cytometry upon staining with
2C44. While 20–30% of CD11c
+ cells were 2C44
+ in LACK-
immunized BALB/c mice, no staining or only background
staining was observed in C3H, C57BL/6 or NOD mice
immunized with LACK (Figure 1A). We next investigated whether
2C44 bound to I-A
d-expressing A20 B lymphoma cells pulsed with
truncated versions of LACK156–173. The binding of 2C44 was not
affected by the removal of I156 or C157 but was completely
prevented by the deletion of F158 (Figure 1B). Removal of one,
two, three or four amino acids at the C terminal end of
LACK156–173, resulted in a progressive decrease in the binding
of 2C44, a result that could be explained by the reduced binding of
these peptides to I-A
d. We next investigated whether I-A
d/LACK
complexes could be visualized in intracellular compartments by
immunogold electron microscopy. To this aim, BALB/c mice
were immunized subcutaneously with either LACK or OVA in
CpG. LN cells were purified 40 hours later, enriched for DCs
using magnetic beads conjugated to anti-CD11c mAb, and fixed.
Frozen sections were stained either with 2C44, an anti-I-A/I-E or
a control isotypic mAb. Upon staining with 2C44, gold grains were
evidenced both on the plasma membrane and on the inner
membrane of intracellular compartments in LACK-immunized
Author Summary
Phagocytosis is a cellular process that allows the engulf-
ment of solid particles such as bacteria or parasites by the
cell membrane and leads to the formation of an intracyto-
plasmic vesicle, the phagosome. Cell types that are capable
of phagocytosis are called phagocytes and include mono-
cytes, macrophages, dendritic cells and eosinophils. All
these cells express Major Histocompatibility Complex class II
molecules, although at different levels. These molecules
allow the presentation of pathogen-derived peptides to
CD4
+ T lymphocytes, a mechanism that alerts the immune
systemofthe occurrenceofaninfectiousdanger.Inorderto
visualize the intracellular compartments in which complex-
es between pathogen-derived peptides and Major Histo-
compatibility Complex class II molecules are formed, we
have generated a monoclonal antibody that reacts to a
peptide derived from an immunodominant antigen of the
intracellular parasite Leishmania major bound to a murine
Major Histocompatibility Complex class II molecule. We
have shown that these complexes are present on the
phagosomes from various types of phagocytes but that
only dendritic cells export these complexes to the plasma
membrane, allowing the activation of pathogen-specific T
cells.
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Only background staining was observed upon staining with an
isotypic control mAb. As expected, staining with an anti-I-A/I-E
mAb showed the presence of gold grains on the plasma membrane
and in intracellular compartments at much higher levels than
those observed with 2C44 (Figure 2).
Different cell types contain amastigotes in the LN of
L. major-infected mice
We next generated a fluorescent parasite that could allow for
the purification of amastigote-containing cells. To this aim, we
constructed a recombinant parasite in which the gene coding for a
DsRed variant was inserted into the ribosomal RNA locus that is
active in amastigotes [22]. BALB/c mice infected with DsRed-
expressing parasites developed lesions as rapidly as those infected
with wild type parasites demonstrating that parasite virulence was
not impaired by DsRed expression (data not shown). To
characterize infected cells, LN cells were purified from BALB/c
mice that had been infected 4 wk earlier with DsRed-expressing
promastigotes, depleted of both T and B lymphocytes, and
analyzed by multicolor flow cytometry upon staining with
antibodies directed to CD11c, CD11b, CD8a, Ly-6C, Ly-6G,
F4/80, B220, Siglec-F and CCR3. DsRed
+ profiles were readily
observed in 8–12% of lymphocytes-depleted LN cells (Figure 3A,
left panel). To visualize eosinophils, live cells were gated on
CD11c
2 CD11b
high Ly-6G
int Ly-6C
int Siglec-F
+ CCR3
+ cells.
Further analysis showed that most (.95%) gated cells were FSC
low
SSC
med/high and appeared in the R1 gate (Figure 3A). 15% of
eosinophils were infected (Supplementary Figure 2) but all
expressed low levels of MHC class II (Figure 3B). To visualize
the other cell types, cells in the R2 gate (Figure 3A, right panel)
were further gated depending on the expression of CD11c,
CD11b, CD8a, B220, Ly6C, Ly6G and F4/80. DCs were
identified as CD11c
+ cells and 13% of them were infected
(Supplementary Figure 3A, left panel). Four DC subsets were
identified depending on the expression of CD11b and B220
(Figure 3C). CD11b
2 B220
+ DCs exhibited a typical plasmacytoid
DC phenotype and 1.3% of these cells were DsRed
+. Whether
infected or not, these cells exhibited low surface levels of MHC
class II. Among CD11b
+ B220
+ DCs, 31% were infected and
expressed high levels of MHC class II while non-infected cells
expressed low to intermediate levels of these molecules. CD11b
+
B220
2 DCs exhibited the phenotype of classical DCs and 25%
were DsRed
+. These cells expressed MHC class II with DsRed
+
cells expressing higher levels of these molecules than DsRed
2 cells.
In contrast to the three other DC subtypes, CD11b
2 B220
2 DCs
were all DsRed
2. These cells were all CD8a
+ and expressed
heterogeneous levels of MHC class II. Macrophages/monocytes
were identified as CD11c
2 CD11b
+ Ly-6G
low/int F4/80
high cells
and 20% of these cells were infected (Supplementary Figure 3B).
These cells expressed low to intermediate levels of MHC class II
(Figure 3D). Neutrophils were identified as CD11c
2 Ly-6C
int Ly-
6G
high F4/80
neg cells and 25% of them were infected (Supple-
mentary Figure 3C). Neutrophils did not express significant
surface levels of MHC class II (Figure 3E). Further flow cytometry
analysis showed that DCs, macrophages/monocytes, eosinophils
and neutrophils accounted for 35%, 25%, 20% and 10% of
DsRed
+ cells respectively (data not shown).
DsRed
+ cells were then sorted by flow cytometry, embedded
with resin and analyzed by electron microscopy. In agreement
with flow cytometry data, about 35% of sorted DsRed
+ cells
exhibited features of macrophages/monocytes such as irregular
cytoplasmic projections or pseudopodia, cytoplasm with a few
mitochondria, lysosomes and residual bodies (features that were
not always all present on the same section), 20–25% of eosinophils
(large ellipsoid granules) and 35–40% of DCs (thin and long
dendrites) (Figure 4). Infected DCs contained an average of 1–3
amastigotes per section (data not shown). Each amastigote was
localized within a parasitophorous vacuole and in most cases
displayed an intact membrane, a nucleus containing diffuse and
condensed chromatin with a nucleolus, golgi apparatus, mito-
chondria, mastigoneme and cortical microtubules (Supplementary
Figure 4 and data not shown). These data strongly suggested that
most amastigotes within DsRed
+ DCs were alive. Infected
eosinophils exhibited large ellipsoid granules and contained one
to two amastigotes per section, each of them localized within a
parasitophorous vacuole (Figure 4). As observed in DsRed
+ DCs,
amastigotes within infected eosinophils displayed recognizable and
unaltered structures (data not shown). Infected macrophages
exhibited a large number of vesicles and contained up to ten
parasitophorous vacuoles per section, each one containing a single
amastigote (Figure 4). In contrast to DCs and eosinophils, some
macrophages contained partially degraded amastigotes with
altered membranes and internal structures (data not shown).
Figure 1. Visualization of I-A
d/LACK complexes by flow
cytometry. (A) Flow cytometry analysis of DCs purified from
immunized mice. Mice of the indicated strains were injected into the
hind footpads with 40 mg of LACK or OVA in CpG. LN cells were
harvested 2 days later and enriched for CD11c
+ cells using magnetic
beads. Cells were stained with 2C44 and anti-CD11c mAb. Data show
representative FACS profiles in mice immunized with LACK (solid line)
or OVA (filled histogram). (B) Flow cytometry analysis of peptide-pulsed
lymphoma cells. A20 mouse B lymphoma cells were pulsed or not with
1 mM of the indicated peptides and analyzed by flow cytometry upon
staining with 2C44 and propidium iodide (PI). Data show representative
FACS profiles after gating on PI
2 cells.
doi:10.1371/journal.ppat.1001154.g001
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d/LACK complexes both at their
surface and on the phagosome membrane
We next investigated whether I-A
d/LACK complexes were
present in phagolysosomes and/or in other cellular compartments.
BALB/c and BALB.B mice were infected with DsRed-expressing
promastigotes and sacrificed 4 weeks later. LN cells were depleted
of both T and B lymphocytes and amastigote-containing cells were
scored and analyzed for the presence of I-A
d/LACK complexes
using immunogold electron microscopy following staining with
2C44, anti-I-A/I-E, anti-LAMP-1 or control isotypic mAbs. Out
of 115 scored amastigote-containing cells, 45 exhibited long
dendrites but no granules indicating that they were DCs. Twenty-
nine amastigote-containing cells exhibited eosinophil-specific
features including large ellipsoid specific granules, with an
electron-dense cristallin nucleus. Forty-one amastigote-containing
cells did not show dendrites or granules but exhibited pseudopodia
and a large number of vesicles suggesting that they were
macrophage-related cells. In amastigote-containing DCs stained
with 2C44, gold grains were readily detected on the plasma
membrane, in phagosomes and on their membrane, and on much
smaller cytoplasmic vesicles (Figure 5A). On the plasma mem-
brane, gold grains were evenly distributed over the whole cell
surface including dendrites. Within infected DCs, gold grains were
found on the phagosome membrane and could clearly be
evidenced on its inner side in some sections. Gold grains were
also present within the amastigote. Gold grains were much less
abundant and sometimes absent on the plasma and phagosome
membranes of highly infected DCs (3–10 phagosomes per section)
as compared to other DCs (1–2 phagosomes per section) (data not
shown). This latter result suggested that the generation and/or the
stability of I-A
d/LACK complexes were influenced by parasite
load and/or the DC physiological state. Most DCs also exhibited
small cytoplasmic vesicles that did not contain parasite but
exhibited gold grains mainly on their membrane. These vesicles
exhibited a diameter of 0.2–0.5 mM and some of them exhibited
features of multi vesicular bodies (MVB) including a round to oval
shape with smaller vesicles inside and a double membrane
(Figure 5B). Gold grains were also observed in all 2C44
+
compartments upon staining with an anti-I-A/I-E mAb
(Figure 5C). Co-staining with anti-LAMP-1 and 2C44 revealed
that 2C44
+ phagosomes as well as MVB-like vesicles expressed
LAMP-1 (Figure 5D and data not shown). Only background
staining was observed in BALB/c DCs stained with a control
isotypic mAb and in BALB.B DCs stained with 2C44 (Figure 5E
and data not shown). Altogether, our results unambiguously show
that I-A
d/LACK complexes are present at the surface of infected
DCs as well as on the inner side of the phagosome membrane and
of smaller vesicles that did not contain amastigotes.
Infected macrophages and eosinophils exhibit I-A
d/LACK
complexes on the phagosome membrane but not at
their surface
Analysis of DsRed
+ macrophages/monocytes by immunogold
electron microscopy upon staining with 2C44 demonstrated the
presence of gold grains in the phagosome and on the phagosome
membrane, and in cytoplasmic vesicles, but not on the cell surface
(Figure 6A and 6C). As compared to 2C44
+ vesicles in DCs,
2C44
+ vesicles in macrophages/monocytes were larger and
exhibited diameters ranging from 0.2 to 1.0 mm. Some of the
largest 2C44
+ vesicles also exhibited electron-dense structures
similar to Leishmania kinetoplast suggesting that they were
phagosomes in which the amastigote was being killed (data not
shown). Of note, and in contrast to those observed in phagosomes,
gold grains were homogeneously distributed in large 2C44
+
vesicles but only scarcely on their membrane.
Unexpectedly, gold grains were also observed in amastigote-
containing eosinophils upon staining with 2C44 (Figure 6B and
6D), but not with a control isotypic mAb (data not shown). In these
cells, gold grains were only observed in the phagosome and on the
phagosome membrane. Co-staining revealed that 2C44
+ phago-
somes also displayed LAMP-1 (data not shown). Furthermore,
staining with an anti-I-A/I-E mAb revealed that MHC class II
molecules were present on the phagosome membrane but not on
the plasma membrane (data not shown).
Altogether, these results suggest that macrophages/monocytes
and eosinophils can capture L. major amastigotes, process parasite
antigens and display MHC/peptide complexes on the phagosome
membrane, but are unable to transport these complexes to the cell
surface.
Quantitative analysis of I-A
d/LACK complexes on the
plasma and the phagosome membranes
To obtain quantitative data, we counted the number of gold
grains per micron on the phagosome and the plasma membranes
in different cell types upon staining with 2C44, anti-I-A/I-E or a
control mAb (Figure 7A). Upon staining with 2C44, amastigote-
containing DCs exhibited 30-40 dots per micron on both the
phagosome and the plasma membranes. The number of dots per
micron on the plasma and the phagosome membranes was also
similar upon staining with anti-I-A/I-E mAb and 20–50 fold
higher than with a control mAb. In contrast to DCs, the number
of dots per micron in macrophages/monocytes stained with 2C44
was much higher on the phagosome membrane than on the
plasma membrane (22.5+/23.9 versus 1.4+/20.5, p,0.0001).
Similar data were observed upon staining with an anti-I-A/I-E
mAb. Likewise, the number of dots per micron in eosinophils
stained with 2C44 was 16.4+/21.4 on the phagosome membrane
as compared to 0.35+/20.06 on the plasma membrane
(p,0.0001).
As another method to estimate the levels of I-A
d/LACK
complexes at the cell surface, lymphocyte-depleted LN cells from
4 wk-infected BALB/c mice were analyzed by flow cytometry
after staining with antibodies directed to various surface markers
and 2C44 or a control isotypic Ig (Figure 7B). While DsRed
2 DCs
exhibited the same profile upon staining with 2C44 and a control
Ig, DsRed
+ DCs exhibited a bimodal distribution upon staining
with 2C44 with 30% of these cells that were 2C44
+. In contrast to
DCs, macrophages/monocytes, eosinophils and neutrophils,
whether infected or not, exhibited the same profile upon staining
with 2C44 and a control Ig (Figure 7B and data not shown).
To independently estimate the amount of I-A
d/LACK
complexes at the cell surface, lymphocytes-depleted LN cells from
4 wk-infected BALB/c mice were sorted into different cell types
and incubated with the highly sensitive LACK-specific LMR7.5
Figure 2. Visualization of I-A
d/LACK complexes by immunogold electron microscopy. BALB/c mice were injected into the hind footpads
with 40 mg of LACK in CpG. LN cells were harvested 2 days later and enriched for CD11c
+ cells using magnetic beads. Cells were frozen and ultrathin
cryosections were analyzed by electron microscopy after immunogold labelling with 2C44 (upper panel), anti-I-A/I-E (middle panel) or control isotypic
(lower panel) mAbs. Representative photographs are shown. Intracellular Compartments (IC) and Extracellular Compartments (EC) are indicated.
Arrows point to dendrites.
doi:10.1371/journal.ppat.1001154.g002
Peptide/MHC Complexes in Phagosomes
PLoS Pathogens | www.plospathogens.org 5 October 2010 | Volume 6 | Issue 10 | e1001154Figure3.Flowcytometryanalysis ofLNcells.Lymphocyte-depleted LNcells from4 wk-infectedBALB/c mice wereanalyzed byflowcytometryafter
stainingwithmAbsdirectedtoCD11c,CD11b,Ly-6C,Ly-6G,F4/80,Siglec-F,CCR3,B220andI-A/I-E.DatashowrepresentativeFACSprofilesaftergatingon
the indicated populations. Numbers indicate mfi. (A) All cells. The percentage of DsRed
+ cells in the gated population is indicated (left panel). The right
panel shows the R1 and R2 gates that were used later in this study. (B) Eosinophils. (C) Dendritic cells. (D) Macrophages/monocytes. (E) Neutrophils.
doi:10.1371/journal.ppat.1001154.g003
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+ cells, CD11c
2 cells
did not stimulate LMR7.5 hybridomas to secrete IL-2 in the
absence of added LACK peptide (Figure 8A). In the presence of
peptide, CD11c
+ cells induced high levels of IL-2 while CD11c
2
cells induced only very low levels at the highest APCs/T cell ratio.
We also tested the ability of different DsRed
+ and DsRed
2 cell
populations to stimulate LMR7.5 hybridomas. In the presence or
in the absence of LACK peptide, DsRed
+ DCs induced LMR7.5
hybridomas to secrete relatively high amounts of IL-2, while
DsRed
+ eosinophils and DsRed
+ neutrophils failed to do so.
DsRed
+ macrophage/monocytes induced very low levels of IL-2 at
the highest APCs/T cell ratio and only in the presence of LACK
peptide (Figure 8B). As expected, neither DsRed
2 eosinophils nor
DsRed
2 macrophage/monocytes or neutrophils induced IL-2
secretion (data not shown). However, low levels of IL-2 were
secreted by LMR7.5 hybridomas in the presence of DsRed
2 DCs
without added LACK peptide (Figure 8C) suggesting that these
cells display low levels of I-A
d/LACK complexes at their cell
surface. Of note, these low levels could not be detected when
DsRed
2 DCs were analysed by flow cytometry after staining with
2C44, a result that was not unexpected, given the high sensitivity
of LMR7.5 hybridomas.
Altogether, our data demonstrated that I-A
d/LACK complexes
were present at the surface of infected DCs as well as on the
phagosome membrane. In contrast, infected eosinophils and
infected macrophages/monocytes both exhibited I-A
d/LACK
complexes on the phagosome membrane, but not on the plasma
membrane.
Discussion
Here, we have tried to visualize MHC class II molecules loaded
with a pathogen-derived peptide at the surface and in the
intracellular compartments of phagocytic cells that had been
infected with Leishmania major in vivo. To achieve this goal, we have
generated a recombinant parasite expressing a fluorescent tracer
and a mAb reacting to an antigenic peptide derived from the
parasite LACK antigen bound to I-A
d MHC molecules.
Amastigotes-containing DCs, macrophages/monocytes and eosin-
ophils were readily identified by both flow cytometry and electron
microscopy. Among these phagocytes, DCs accounted for 35% of
all infected cells. In this study, we have classified DCs into four
subsets depending on the expression of CD11b and B220. Among
these subsets, CD11b
2 B220
+, CD11b
+ BB20
+, CD11b
+ B220
2,
but not CD11b
2 B220
2, exhibited DsRed
+ profiles. While the
frequency of DsRed
+ cells among CD11b
+ B220
+ and CD11b
+
BB20
2 were 31% and 25% respectively, only 1.3% of CD11b
2
B220
+ were DsRed
+. Our data are in agreement with a previous
study in which both B220
+ DCs and B220
2 DCs were found to be
infected [23]. However, while Baldwin and colleagues concluded
from their data that a significant proportion of plasmacytoid DCs
were infected, we found that only 1.3% of these cells were DsRed
+.
This discrepancy may be explained by the fact that Baldwin and
colleagues considered all B220
+ CD11c
+ cells to be plasmacytoid
DCs while we could discriminate between bona fide CD11b
2 B220
+
DCs and a non described CD11b
+ B220
+ DCs subset that exhibit
the specific feature of up-regulating MHC class II upon infection
with L. major.
Figure 4. Morphological analysis of DsRed
+ cells. Lymphocyte-
depleted LN cells from 4 wk-infected BALB/c mice were analyzed by
electron microscopy. Data show representative pictures of amastigote-
containing DCs (upper panel), eosinophils (middle panel), and
macrophage/monocytes (lower panel). Red and white arrows point to
the phagosome membrane and to the eosinophil granules respectively.
N: nucleus of the cell; P: phagosome.
doi:10.1371/journal.ppat.1001154.g004
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infected with Leishmania. It is conceivable that amastigotes enter all
DCs but that the various DC subsets differ in their ability to
support parasite replication. Alternatively, since the uptake of
L. major by DCs is mediated by Fcc receptors RI and RIII [24], it is
possible that these receptors are differentially expressed by the
different DC subsets. In agreement with this latter hypothesis, a
molecule that is involved in the phagocytosis of Leishmania major
parasites, SIRP-b, was found to be expressed on CD8a
2 but not
on CD8a
+ DCs [25]. As CD11b
2 B220
2 DCs are all CD8a
+, this
may explain why we found that CD11b
2 B220
2 DCs were not
infected.
While DCs accounted for 35% of infected cells in BALB/c mice
in the present study, as many as 70–75% of infected cells were
identified as DCs in C57BL/6 mice 4 weeks after infection
[26,27]. Furthermore, Leon et al. found that amastigote-containing
eosinophils accounted for 2–3% of infected cells in C57BL/6 mice
while 20–25% of infected cells were eosinophils in the present
study [26]. One might speculate that differences in parasite load
between susceptible and resistant mice could account for these
distinct infected cells profiles.
One of the major findings of this paper is that various types of
amastigote-containing phagocytes express I-A
d/LACK complexes
in the phagosome and on its inner membrane but that only DCs
export these complexes at their surface. Immunogold electron
microscopy data revealed that in DCs, I-A
d/LACK complexes
were present on the plasma membrane and evenly distributed over
the whole cell surface including dendrites. I-A
d/LACK complexes
were also present in amastigote-containing LAMP-1
+ phagosomes
and on the inner side of their membrane. Moreover, I-A
d/LACK
complexes were present within amastigotes, a result that is in
agreement with previous studies that have shown that amastigotes
internalize MHC class II molecules of their host cells [17]. Lastly,
I-A
d/LACK complexes were found at the surface of small
cytoplasmic LAMP-1
+ vesicles that did not contain parasite but
exhibited a diameter of 0.2–0.5 mM and for some of them, features
of MVB. In macrophages, I-A
d/LACK complexes were also
present in amastigote-containing LAMP-1
+ phagosomes and on
the inner side of their membrane and in large vesicles (diameters
ranging from 0.2 to 1.0 mm) in which, at least for some of them,
Leishmania remnants could be detected, suggesting that the
amastigote was being killed. In contrast to what was observed in
DCs, these vesicles exhibited 2C44 staining essentially in the
lumen. Finally, in eosinophils, I-A
d/LACK complexes could only
be detected in the phagosome and its membrane. This was shown
both by immunogold electron microscopy following staining with
2C44 and by performing an ex vivo antigen presentation assay
using a sensitive LACK-specific T cell hybridoma. In a recent
paper, Filipe-Santos and her colleagues have examined the
behavior of pathogen-specific CD4
+ T cells at the site of L. major
infection in BALB/c mice. Data showed that interactions between
the infected phagocytes and parasite-specific CD4
+ T cells were
heterogeneous, involving both stable and dynamic contacts, and
that only a fraction of infected cells induced arrest or deceleration
of pathogen-specific T cells. While local variation in T cell access
to infected cells could account for these observations, this
phenomenon could also be the result of the absence of peptide/
MHC complexes at the surface of some infected cells as we have
observed in the present study.
It is tempting to speculate why some phagocytes are infected
with L. major but do not present parasite peptides bound to MHC
class II at their surface. In agreement with other studies that
showed that macrophages/monocytes could process antigens and
assemble peptide/MHC complexes in intracellular compartments,
we found that macrophages infected with L. major exhibited I-A
d/
LACK complexes on the phagosome membrane. However, these
complexes were not found on the plasma membrane suggesting
that L. major has developed escape mechanisms preventing the
translocation of these complexes from the phagosome to the cell
surface. Several years ago, Antoine and his colleagues showed in
bone marrow-derived macrophages that MHC class II molecules
were retained in the phagolysosome and part of these molecules
were internalized by amastigotes preventing L. major-infected cells
to present parasite as well as exogenous antigens [16,17]. While
this phenomenon could explain the absence of I-A
d/LACK
complexes on the plasma membrane on DsRed
+ macrophage/
monocyte, it should be noticed that we readily detected I-A
d/
LACK complexes on the membrane of vesicles that, at least for
some of them,exhibited features of MVB including a round to oval
shape with smaller vesicles inside and a double membrane.
Therefore, it is tempting to speculate that L. major has evolved an
additional escape mechanism preventing the translocation of
peptide/MHC complexes from the MVB to the cell surface.
Are I-A
d/LACK complexes assembled in amastigote-containing
phagosomes in vivo? Although our results unambiguously show that
I-A
d/LACK complexes are present in the phagosome of infected
phagocytes, it remains possible that LACK or LACK-derived
peptides are translocated from the phagosome to other cellular
compartments and eventually loaded onto I-A
d molecules before
being transported to the phagosome membrane. We do not favor
this latter hypothesis for two reasons. First, phagosomes contain
both MHC molecules and H2-M that is required for the loading of
peptides onto MHC class II molecules [15]. Secondly, in
eosinophils, I-A
d/LACK complexes were only detected in the
phagosome and not in other cellular compartments. Therefore,
this result suggests that I-A
d/LACK complexes are assembled in
amastigote-containing phagosomes before being transported to the
cell surface in DCs. In agreement with this hypothesis, we found
that the cytoplasm of infected DCs contained 2C44
+ vesicles and
that some of them were similar to the long tubular organelles that
Figure 5. Distribution of I-A
d/LACK complexes in intracellular DC compartments. Ultrathin cryosections of DCs purified from 4 wk-infected
BALB/c mice were analyzed by immunogold electron microscopy after staining with either 2C44 (A, B), anti-I-A/I-E (C), a combination of a anti-LAMP-1
mAb (10 nm gold particles) and 2C44 (15 nm gold particles) (D), or a control isotypic mAb (E). (A) Data show different magnification views of a typical
micrograph showing a DC harboring one single phagosome following staining with 2C44. Upper left panel: a low magnification view showing
dendrites, the nucleus and an amastigote-containing phagosome. Lower left panel: a high magnification view showing the phagosome. Upper right
panel: a high magnification view (after a 90u left rotation) showing gold grains located either on the cytoplasmic membrane or on small vesicles.
Lower right panel: a high magnification view showing the two double sheets of the phagosome membrane with an intense 2C44 labelling of the
inner side of the phagosomal membrane. (B) High magnification view showing of a small vesicle exhibiting gold grains both on peripheral and
internal membranes. (C) An amastigote-containing phagosome stained with an anti-I-A/I-E mAb showing an intense labelling of the phagosomal
membrane, small vesicles and the cytoplasmic membrane. (D) A fragment of an amastigote-containing phagosomal membrane labelled with both
2C44 (white arrowheads) and an anti-LAMP-1 mAb (black arrowheads). (E) An amastigote-containing phagosome stained with a control isotypic mAb.
The red and black arrows point to the phagosome membrane and dendrites respectively. N: phagosome nucleus; EC: extracellular compartment;
V: vesicles.
doi:10.1371/journal.ppat.1001154.g005
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d/LACK complexes in eosinophil and macrophage intracellular compartments. Ultrathin cryosections of LN
cells purified from 4 wk-infected BALB/c mice were analyzed by immunogold electron microscopy after staining with either 2C44. (A) A
representative image of macrophages/monocytes. Left panel: a low magnification view of a macrophage exhibiting one amastigote-containing
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this latter study, these vesicles could mediate transport to the
plasma membrane.
It is of interest that I-A
d/LACK complexes could be detected at
the cell surface since LACK accounts for only 0.01% of the total
amount of proteins expressed by amastigotes. This phenomenon is
likely to be related to the very long half time life of the I-A
d/
LACK complexes. Our results may also suggest that I-A
d/LACK
complexes account for a significant proportion of surface peptide/
MHC complexes in amastigote-containing DCs, possibly explain-
ing why this parasite antigen is the main target of the CD4
+ T cell
response directed to L. major [18].
Several mAbs recognizing peptides bound to MHC class II
molecules have been described. A set of mAbs, all IgM, were
produced against peptides from the rat myelin basic protein bound
to I-A
s [29]. Aw3.18 and C4H3 both reacted to HEL peptides
bound to I-A
k [30,31,32], 30.2 recognized a fragment of human
invariant chain (CLIP) bound to I-A
b [33] and Yae reacted to a
peptide from the I-Ea chain bound to I-A
b [34,35,36,37].
Although these mAbs were used in some studies, they cross-
reacted with MHC molecules that were loaded with peptides other
than the desired fragment of the model antigen. For example,
C4H3 bound to a subset of I-A
k molecules loaded with certain self-
peptides, and therefore the absolute background of C4H3 staining
was influenced by the total amount of I-A
k present on the APC
[38]. In this study, we have generated four mAb that were
identified on the basis of their ability to bind to I-A
d-expressing
fibroblasts loaded with LACK peptide. Two out of these four
mAbs bound to DCs from LACK-immunized mice, but also to
DCs from OVA-immunized animals precluding their use to
identify the cells that presented LACK in vivo. In striking contrast,
2C44 only bound to DCs from LACK-immunized mice and
therefore, was suitable to identify the APCs that presented LACK
in vivo. Furthermore, binding of 2C44 to I-A
d/LACK was
characterized by a low equilibrium dissociation constant of
1.1 nM as demonstrated by BIAcore analysis. Although the
affinity as a thermodynamic parameter is not necessarily related to
the specificity of a mAb, we can speculate that the exquisite
specificity of 2C44 as compared to 2E60, 2F74 and 2X8 is due to
recognition of a higher number of atoms of the I-A
d/LACK
complex, leading to a better stabilization of the antibody-peptide/
MHC complex.
MHC class II molecules, including I-A
d, exhibit an open groove
that can accommodate antigenic peptides of different lengths [39].
Furthermore, analyzing naturally processed antigenic peptides
using mass spectroscopy revealed that MHC class II-bound
peptides could exhibit the same core but different amino- or
carboxy-terminal extremities. Use of truncated peptides indicated
the binding core of LACK156–173 to be residues 163–171 and
suggested the following amino acid register from P1 to P9:
EHPIVVSGS with E163,I 166,V 168 and S171 being the anchor
residues [20]. In agreement with this hypothesis, LACK-specific
LMR7.5 hybridomas readily secreted IL-2 when incubated with
LACK161–172 and syngeneic APCs and LACK161–173 bound to
I-A
d with high avidity. Furthermore, substitution of I166 by an
alanine resulted in a dramatic decrease in the half life time of the
I-A
d/LACK161–173 complexes. Characterization of 2C44 showed
that its binding to I-A
d/LACK complexes was not affected by the
removal of C157, but completely prevented by deletion of F158.
Because all amastigote-containing DCs were stained with 2C44,
this suggested that naturally processed LACK peptides had
retained F158. Therefore, whatever proteases are involved in the
processing of LACK by amastigote-containing DCs, trimming of
the LACK peptide is limited to a minimal peptide containing F158
further suggesting that this peptide is protruding from the I-A
d
peptide-binding groove by at least 5 amino acids on the amino-
terminal side.
Participation of amino-terminal flanking residues in the
hydrogen-bonding network stabilizing the complex has been
observed for multiple peptide–class II MHC complexes from both
human and mouse, and appears to be a universal feature of this
interaction [40]. Furthermore, interactions involving amino-
terminal flanking residues have been shown to confer resistance
to editing by H2-DM in peritoneal macrophages incubated with
liposome-encapsulated HEL peptides [41]. As H2-DM is present
in the membrane of amastigote-containing phagosomes [42], our
observation that the LACK peptide is protruding from the I-A
d
peptide-binding groove on the amino-terminal side both on the
phagosome membrane and at the cell surface is consistent with a
protective role of this region to H2-DM editing of parasite antigens
in vivo.
Monoclonal antibodies to MHC-peptide complexes have been
widely used to study either antigen presentation in vitro or in mice
immunized with recombinant antigens. To our knowledge, this
study is the first one in which such a reagent was successfully used
to study the presentation of a non-recombinant parasite antigen in
an infectious disease model. Most importantly, the unique features
of the 2C44 mAb allowed us to gain insight into the molecular and
cellular mechanisms that are involved in the processing and the
presentation of parasite antigen in vivo.
Materials and Methods
Ethics statement
Animal work has been conducted according to recommenda-
tions of the national laboratory animal use and care committee
(CNREEA). Animal experiments were all performed in our animal
facility that was approved by the French Ministry of Agriculture
(agreement number: B 06-152-5). The protocols on live animals
were approved by the local animal ethic committee for animal
care and use (comite ´r e ´gional d’e ´thique pour l’expe ´rimation
animale (CREEA) Cote d’azur).
Mice and parasites
BALB/c (H-2
d), BALB.B (H-2
b), C57BL/6 (H-2
b), NOD (H-
2
g7), C3H (H-2
k) mice, were purchased from Harlan (Bicester,
UK). Mice were housed under Specific Pathogen Free (SPF)
conditions and used between 6 and 10 weeks of age. 16.2b mice
were crossed to BALB/c mice for 12 generations [21]. All animal
studies were conducted according to the national laws on animal
care and use. L. major promastigotes (World Health Organization
strain WHOM/IR/-/173) were grown in M199 medium
phagosome and several vesicles (black arrows). The photograph shows gold grains on the phagosome membrane and in the vesicles but not at the
cell surface. Right panel: a high magnification view of the phagosome. Red arrows point to the phagosomal membrane. (B) A representative image of
eosinophil. Left panel: a low magnification view showing an eosinophil containing three amastigote-containing phagosomes and typical ellipsoid
granules (white arrows). The photograph shows gold grains on the phagosome membrane but not at the cell surface. Right panel: a high
magnification view of an eosinophil phagosome. Red arrows point to the phagosomal membrane. (C, D, E) High magnification views of the plasma
membrane in a representative macrophage/monocyte (C), eosinophil (D) and DC (E). EC: extracellular compartment. PM: plasma membrane.
doi:10.1371/journal.ppat.1001154.g006
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d/LACK complexes on the phagosome and the plasma membranes in infected phagocytes.
Lymphocyte-depleted cells from 4 wk-infected BALB/c mice were enriched for DsRed
+ cells. (A) Number of dots per micron. Cells were analyzed by
immunogold electron microscopy after staining with 2C44, an anti-I-A/I-E or a control mAb. Cell types were identified according to their morphology
and the number of dots per micron of membrane was counted. At least 30 sections were analyzed for each cell type and each staining. Data show the
mean +/2 s.e.m. (B) Flow cytometry analysis. Cells were analyzed by FACS after staining with 2C44 (filled histograms) or a control Ig (dotted line).
Data show representative profiles after gating on CD11c
+ cells (left panels) or CD11c
2 CD11b
+ F4/80
+ Ly6G
2 cells (right panels).
doi:10.1371/journal.ppat.1001154.g007
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from 4 wk-infected BALB/c mice were sorted into different cell types and the indicated numbers of cells were incubated with 10
5 LMR7.5 T cell
hybridomas with or without 1 mM of LACK156–173. Supernatants were harvested 24 hours later and analyzed for IL-2 content by ELISA. (A) Cells were
sorted into CD11c
+ (filled circles) and CD11c
2 (empty circles) cells. Data show the results of a typical experiment (out of 5). (B) DsRed
+ populations:
CD11c
+ (filled circles), eosinophils (grey squares), macrophages/monocytes (empty triangles) neutrophils (filled squares). Data show results of a
typical experiment (out of 3). (C) CD11c
+ cells were sorted into DsRed
+ cells (filled squares) and DsRed
2 cells (filled squares). Data show results of a
typical experiment (out of 4).
doi:10.1371/journal.ppat.1001154.g008
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prepared by inserting the gene coding for a DsRed variant [43]
into the ribosomal RNA locus. Recombinant promastigotes were
selected as previously described [22].
Reagents, mAb and T cell hybridomas
LACK recombinant protein was purified as described [18].
OVA and RIBI were purchased from Sigma-Aldrich Chimie
SARL (Lyon, France). CpG was purchased from Coley Pharma-
ceutical (USA). I-A
d/LACK dimers were produced and purified as
described [21]. The following mAbs were purchased from BD
Biosciences (Le Pont de Claix, France): RA3-6B2, anti-B220; 2G9,
anti-I-A
d/I-E
d, M1/70, anti-CD11b; HL3, anti-CD11c; 145-
2C11, anti-CD3e; AL21, anti-Ly-6C; 2.4G2, anti-FcR, e50-
2440, Anti-Siglec-F; rb6-8c5, anti-Ly-6G; 3/23, anti-CD40;
KT4.1, anti CD8a. Anti-CD3e (clone 363.29.B) was purchased
from Abcam. Anti-F4/80 mAb was obtained from the CalTag
(Burlingame CA, USA). Anti-CCR3 mAb (clone 83102) and
recombinant IL-2 were purchased from BD Biosciences. The
peptides LACK156–173 (ICFSPSLEHPIVVSGSWD), OVA323–339,
and the indicated LACK truncated peptides were synthesized by
Mimotopes France (Paris, France). LACK-specific LMR7.5 T cell
hybridoma [44] and A20 lymphoma B cells [45] have been
previously described.
Generation of anti-I-A
d/LACK antibodies
240 mg of I-A
d/LACK dimers in 200 ml of PBS were mixed
with 200 ml of RIBI (Sigma-Aldrich Chimie SARL, Lyon, France)
and 50 ml of this solution was injected in the footpad of 16.2b
transgenic mice on days 1 and 8. Mice were immunized in the
same footpad on days 15 and 18 with 5 mg of peptide/MHC
dimers in PBS. Popliteal LN cells were harvested 15 h after the last
immunization and fused to AG8X63 myeloma cells according to
standard protocols. Cells were plated in 15 X flat-bottomed 96
well-plates in RPMI 1640 supplemented with non essential
aminoacids and 10% FCS. Supernatants were screened by flow
cytometry. Briefly, I-A
d-transfected fibroblasts were pulsed for 2 h
at 37uC with 20 mM of either LACK156–173 or OVA323–339.2 610
5
cells were washed twice with PBS containing 1% BSA,
resuspended in 100 ml of supernatants and incubated for 1 h at
4uC. Cells were washed in PBS containing 1% BSA and fibroblast-
bound antibodies were revealed using FITC-conjugated goat anti-
mouse Ig.
Biosensor experiments
The BIACORE 3000 system, sensor chip CM5, surfactant P20,
amine coupling kit containing N-hydroxysuccinimide (NHS) and
1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) were from
BIACORE (Uppsala, Sweden). Streptavidin was obtained from
Sigma. All biosensor assays were performed with Hepes-Buffered
Saline (HBS) as running buffer (10 mM Hepes, 150 mM NaCl,
3.4 mM EDTA, 0.02% surfactant P20, pH 7.4). Streptavidin was
immobilized on CM5 sensor chips by amine coupling according
the manufacturer’s protocol. The amount of immobilized mAb
was approximately 5 ng/mm
2. The four biotinylated mAb were
immobilized on the streptavidin chip, each on one channel, at a
concentration of 10 mg/ml and at a flow rate of 10 ml/min for 1
minute. The channels were washed with 10 ml of regenerating
solution (KSCN 0.51 M, citrate 0.2 M, pH=5). The amounts of
bound mAb were 2.0, 2.4, 2.1 and 1.3 ng/mm
2 for 2F74, 2C44,
2X80 and 2E60, respectively. I-A
d/LACK and I-A
d/Ig dimers
were used at concentrations of 50 to 400 nM and kinetic
parameters were measured at 25uC. In the association phase,
dimers were fluxed over the antibody chip at a flow rate of
20 ml/min for 7 minutes. In the dissociation phase, buffer alone
was fluxed over the chip for 10 minutes. After each cycle, 10 mlo f
regenerating buffer was used to return to the start value. The
kinetic parameters were calculated using the BIAeval 3.1 software.
Global analysis was performed using the bivalent analyte model
after subtracting the sensorgrams of the I-A
d/Ig control dimer
from that of the I-A
d/LACK dimer. The bivalent analyte model
was used since the model fitted best to the experimental values.
Immunization and infection
Immunization was performed by injecting 6 week-old BALB/c
mice in both footpads with a truncated version of LACK (40–
50 mg per footpad) together with 25 mg of CpG. Cells from the
draining lymph nodes were prepared 40 hours later, labeled with
fluorescent antibodies and analyzed by flow cytometry. Infection
was performed by injecting 6 wk-old BALB/c mice with 10
6
purified metacyclic promastigotes in 25 ml per footpad. Mice were
sacrificed 4 wk later.
Cell purification
To prepare DC, LN were digested with a cocktail of DNase I
fraction IX (Roche, diagnostics) (100 mg/ml) and 1.6 mg/ml of
collagenase (400 Mandl U/ml) at 37uC for 45 min. DCs were
positively selected by MACS using N418 (anti-CD11c) magnetic
beads (Miltenyi Biotec, Germany) in the presence of 10% mouse
serum and 5 mM EDTA according to the manufacturer instruc-
tions. Positively selected cells were .95% pure as determined by
flow cytometry following staining with anti-CD11c mAb. To
prepare phagocytes, LN cells were depleted of T and B cells. To
this aim, cells were incubated with anti-CD3 and anti-CD19 mAb,
and CD3
+ and CD19
+ cells were depleted by negative selection
using anti-rat IgG magnetic Dynabeads (Invitrogen, France)
resulting in a cell population containing 12% and 13% of B and
T lymphocytesrespectively (SupplementaryFigure5).Alternatively,
cells were incubated with biotinylated anti-CD3 and anti-CD19
mAb, and CD3
+ and CD19
+ cells were depleted using streptavidin-
coupled magnetic beads (Myltenyi Biotec, Germany), resulting in a
cell population containing 8% and 6% of B and T lymphocytes
respectively (Supplementary Figure 5).
T cell assay
The indicated numbers of cells were incubated with 10
5
LMR7.5 hybridomas with or without 1 mM of LACK156–173 in
DMEM supplemented with 2 mM L-glutamine, 10% heat-
inactivated FCS, 5610
25 M 2-mercaptoethanol, 100 mg/ml
penicillin and 100 U/ml streptomycin in the wells of U-bottomed
96 well-plates. Supernatants were harvested 24 h later, and IL-2
contents were measured by ELISA.
Flow cytometry
Cells were analyzed by flow cytometry using a FACSCanto or a
LSR II with the FACS Diva software (Becton Dickinson, San Jose,
CA). Cell sorting was carried out using a FACS Aria (Becton
Dickinson, San Jose, CA).
Electron microscopy
Flow-sorted cells were primary fixed with 1.6% glutaraldehyde
in 0.1 M phosphate buffer pH 7.5, then at 4uC with 1% osmium
tetroxide in 100 mM cacodylate buffer pH 7.5. Pellets were
washed five times in water, dehydrated in increasing acetone series
and embedded in epoxy resin. 70 mM thin sections were prepared
and contrasted for observation with a Philips CM12 or Jeol 1400
electron microscope.
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Immunogold labeling was performed on ultrathin cryo-sections
of FACS-purified DsRed
+ cells. Cells were fixed for 1 h at 4uCi n
0.1 M phosphate buffer pH 7.5 containing 4% paraformaldehyde
and 0.2% glutaraldehyde. Cells were then washed with phosphate
buffer (PBS) containing 50 mM NH4Cl. Small blocks were
infiltrated with 2.3 M sucrose, frozen in liquid nitrogen and then
cut on a dry diamond knife at 2120uC. Ultrathin 70 nm sections
were then collected on formvar-coated nickel grids and processed
for immunochemistry. Grids were deposited face down on the top
of small drops of the following solutions: PBS containing 50 mM
NH4Cl for 10 min, PBS containing 1% BSA for 5 min, PBS
containing the relevant mAbs in 1% BSA for 1 h, PBS containing
1% BSA for 10 min, PBS containing 0.1% BSA for 5 min, PBS
containing 1% BSA and either 10 or 15 nm colloidal gold
conjugated anti-mouse IgG antibodies for 30 min, PBS containing
0.1% BSA for 5 min, PBS for 5 min twice, PBS containing 1%
glutaraldehyde for 5 min and distilled water for 5 min. Grids were
then embedded in methylcellulose as described elsewhere [46].
Preparations were observed with a Philips CM12 or a Jeol 1400
electron microscope operating at 80 kV equipped with CCD
camera (Olympus SIS, Germany). Micrographs were systemati-
cally taken on labeling area to visualize the number of beads on
the structure. No signal was observed when the first antibody was
omitted.
Supporting Information
Figure S1 Flow cytometry analysis of LN cells from immunized
mice stained with different mAbs reacting to I-A
d/LACK
complexes. BALB/c mice were immunized or not with either
LACK or OVA in CpG. LN cells were purified 2 days later,
enriched for CD11c
+ cells using magnetic beads and stained with
either 2C44, 2F74, 2E60 or 2X8. Data show representative FACS
profiles after gating on CD11c
+ cells.
Found at: doi:10.1371/journal.ppat.1001154.s001 (0.06 MB
TIF)
Figure S2 Lymphocyte-depleted cells from 4 wk-infected
BALB/c mice were analyzed by multicolor flow cytometry. Data
show representative profiles after gating successively on live cells
(upper left panel), CD11b
high CD11c
2 cells (G1, upper right
panel), Ly-6G
int Ly-6C
int (G2, lower left panel) and Siglec-F
high
CCR3
+ cells (G3, lower right panel). The frequency of DsRed
+
cells in the gated population is indicated.
Found at: doi:10.1371/journal.ppat.1001154.s002 (0.31 MB
TIF)
Figure S3 Flow cytometry analysis of DCs, macrophages/
monocytes and neutrophils. Lymphocyte-depleted cells from
4 wk-infected BALB/c mice were analyzed by multicolor flow
cytometry after gating out eosinophils (R2 gate defined in Figure 3).
(A) DCs. Data show representative profiles before (left panel) and
after gating on G1 (right panel). (B) Macrophages/monocytes.
Data show representative profiles before (left panel) and after
gating successively on G2 (middle panel) and G3 (right panel). (C)
Neutrophils. Data show representative profiles before (left panel)
and after gating successively on G4 (middle panel) and G5 (right
panel). The frequency of DsRed
+ cells in the gated population is
indicated.
Found at: doi:10.1371/journal.ppat.1001154.s003 (0.46 MB TIF)
Figure S4 High-resolution electron microscopy analysis of
amastigote-containing phagosomes. Data show enlargments of
DC phagosomes. The left photograph shows 2 phagosomes with
the parasite nucleus, membrane and cortical microtubules. The
right photograph shows a high magnification view of the
phagosomal and amastigote membranes. P: phagosome; C:
cytoplasm.
Found at: doi:10.1371/journal.ppat.1001154.s004 (2.70 MB TIF)
Figure S5 Flow cytometry analysis of LN cells before and after
depletion of lymphocytes. Lymphocyte-depleted cells from 4 wk-
infected BALB/c mice were analyzed by flow cytometry before (A)
or after depletion of CD3
+ and CD19
+ lymphocytes using
streptavidin-coupled beads (B) or anti-rat Ig Dynabeads (C). Data
show representative FACS profiles after staining with anti-B220
(left panels) or anti-CD3 (right panels) mAbs. Of note, two
different clones of anti-CD3 mAb were used for depletion (145-
2C11) and staining (C363.29.B). The frequency of cells that are
stained with the indicated mAb is shown.
Found at: doi:10.1371/journal.ppat.1001154.s005 (0.15 MB TIF)
Table S1 Kinetics parameters of the binding of different mAbs
to I-A
d/LACK dimer. The indicated mAbs were biotinylated and
immobilized on a streptavidin chip that was fluxed with either
I-A
d/LACK dimers or I-A
d/Ig control dimers. The kinetics
parameters were calculated using the BIAeval 3.1 software. Global
analysis was performed using the bivalent analyte model after
subtracting the sensorgrams of the I-A
d/Ig control dimer from that
of the I-A
d/LACK dimer.
Found at: doi:10.1371/journal.ppat.1001154.s006 (0.03 MB
DOC)
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